Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Accel Entertainment | ACEL | Apr 26, 2024 | 11.19 | -0.97 |
Accelerate Diagnostics | AXDX | Apr 26, 2024 | 0.93 | -1.61 |
Accenture A | ACN | Apr 26, 2024 | 308.01 | -0.32 |
Acco Brands | ACCO | Apr 26, 2024 | 4.83 | -0.41 |
Accolade | ACCD | Apr 26, 2024 | 7.89 | -14.15 |
Accuray | ARAY | Apr 26, 2024 | 2.19 | +0.46 |
Ace Global Business Acquisition | ACBA | Apr 26, 2024 | 12.09 | -0.08 |
Ace Global Business Acquisition Unit | ACBAU | Apr 26, 2024 | 11.96 | 0.00 |
Acelyrin | SLRN | Apr 26, 2024 | 4.24 | 0.00 |
Achieve Life Sciences | ACHV | Apr 26, 2024 | 4.61 | +0.77 |
Achilles Therapeutics ADR | ACHL | Apr 26, 2024 | 0.76 | -1.86 |
ACI Worldwide | ACIW | Apr 26, 2024 | 33.30 | +1.62 |
Aclarion | ACON | Apr 26, 2024 | 0.34 | -14.18 |
Aclaris Therapeutics | ACRS | Apr 26, 2024 | 1.20 | +0.84 |
ACM Research A | ACMR | Apr 26, 2024 | 27.04 | -4.42 |
Acme United | ACU | Apr 26, 2024 | 41.10 | +1.13 |
ACNB | ACNB | Apr 26, 2024 | 34.16 | +2.89 |
Acorda Therapeutics | ACOR | Apr 26, 2024 | 0.88 | 0.00 |
ACRES Commercial Realty | ACR | Apr 26, 2024 | 13.74 | +0.59 |
ACRES Commercial Realty C Pref | ACR-C | Apr 26, 2024 | 24.05 | -0.46 |
ACRES Commercial Realty D Pref | ACR-D | Apr 26, 2024 | 20.58 | -0.01 |
Acrivon Therapeutics | ACRV | Apr 26, 2024 | 8.46 | -0.12 |
Actelis Networks | ASNS | Apr 26, 2024 | 0.78 | +4.00 |
Actinium Pharmaceuticals | ATNM | Apr 26, 2024 | 6.87 | +4.73 |
Active Bear ETF | HDGE | Apr 26, 2024 | 21.11 | -0.69 |
Active U.S. Real Estate Powershares | PSR | Apr 26, 2024 | 81.18 | +0.04 |
Acuity Brands | AYI | Apr 26, 2024 | 252.16 | +0.17 |
Acumen Pharmaceuticals | ABOS | Apr 26, 2024 | 3.17 | -0.63 |
Acurx Pharmaceuticals | ACXP | Apr 26, 2024 | 2.07 | +2.48 |
Acushnet | GOLF | Apr 26, 2024 | 62.23 | +1.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.